Medistim ASA (OSL:MEDI)
249.00
0.00 (0.00%)
At close: Jan 13, 2026
Medistim ASA Market Cap
Medistim ASA has a market cap or net worth of 4.55 billion as of January 13, 2026. Its market cap has increased by 65.72% in one year.
Market Cap
4.55B
Enterprise Value
4.42B
Revenue
662.18M
Ranking
n/a
PE Ratio
31.97
Stock Price
249.00
Market Cap Chart
Since May 28, 2004, Medistim ASA's market cap has increased from 40.53M to 4.55B, an increase of 11,133.18%. That is a compound annual growth rate of 24.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 4.55B | -3.86% |
| Dec 30, 2025 | 4.74B | 72.95% |
| Dec 30, 2024 | 2.74B | -30.01% |
| Dec 29, 2023 | 3.91B | -7.22% |
| Dec 30, 2022 | 4.22B | -37.01% |
| Dec 30, 2021 | 6.69B | 47.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 2.83B |
| Photocure ASA | 2.02B |
| Thor Medical ASA | 1.83B |
| ArcticZymes Technologies ASA | 1.25B |
| Omda AS | 982.32M |
| Vistin Pharma ASA | 931.24M |
| Gentian Diagnostics ASA | 894.50M |
| Nykode Therapeutics AS | 745.18M |